Novanta Inc. (NOVT)
NASDAQ: NOVT
· Real-Time Price · USD
101.03
-1.74 (-1.69%)
At close: Sep 26, 2025, 3:59 PM
101.03
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT
Novanta Revenue Breakdown
| Period Ending | Jun 27, 2025 | Mar 28, 2025 | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Precision Manufacturing Revenue | 43.84M | 44.58M | 77.67M | 80.03M | 67.39M | 63.23M | 62.85M | 66.85M | 71.81M | 71.96M |
| Precision Manufacturing Revenue Growth | -1.66% | -42.61% | -2.94% | +18.76% | +6.57% | +0.60% | -5.97% | -6.91% | -0.21% | n/a |
| Robotics and Automation Revenue | 77.83M | 78.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Robotics and Automation Revenue Growth | -0.96% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Advanced Surgery Revenue | 60.22M | 56.19M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Advanced Surgery Revenue Growth | +7.17% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Precision Medicine Revenue | 59.16M | 54.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Precision Medicine Revenue Growth | +9.54% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 27, 2025 | Mar 28, 2025 | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Revenue | 21.78M | 21.43M | 23.85M | 24.62M | 19.01M | 17.07M | 19.11M | 15.68M | 20.85M | 17.8M | 16.3M | 24.21M | 29.87M | 26.8M | 26.76M | 1.79M | 23.51M | 22.55M | 20.27M | 17.41M | 17.47M | 15.4M | 17.12M | 11.89M | 15.39M | 15.11M | 14.93M | 17.52M | 18.37M | 15.6M |
| China Revenue Growth | +1.60% | -10.15% | -3.12% | +29.50% | +11.38% | -10.68% | +21.90% | -24.82% | +17.17% | +9.18% | -32.67% | -18.95% | +11.46% | +0.15% | +1393.25% | -92.38% | +4.23% | +11.24% | +16.45% | -0.36% | +13.43% | -10.01% | +43.90% | -22.72% | +1.88% | +1.21% | -14.78% | -4.63% | +17.71% | n/a |
| Germany Revenue | 27.26M | 28.48M | 24.59M | 33.56M | 31.92M | 33.18M | 28.01M | 33.26M | 32.1M | 34.86M | 34.2M | 34.63M | 33.12M | 31.78M | 30.42M | 21.26M | 23.77M | 22.36M | 19.5M | 18.89M | 22.15M | 23.23M | 18.29M | 21.42M | 18.84M | 23.48M | 23.86M | 23.09M | 21.01M | 20.07M |
| Germany Revenue Growth | -4.28% | +15.83% | -26.74% | +5.14% | -3.80% | +18.47% | -15.80% | +3.63% | -7.93% | +1.93% | -1.22% | +4.53% | +4.23% | +4.47% | +43.10% | -10.59% | +6.31% | +14.69% | +3.25% | -14.73% | -4.67% | +27.00% | -14.61% | +13.72% | -19.76% | -1.59% | +3.33% | +9.88% | +4.70% | n/a |
| Other Countries Revenue | 4.38M | 4.65M | 5.2M | 4.16M | 3.68M | 5.36M | 3.42M | 3.78M | 6.99M | 5.15M | 4.44M | 4.01M | 4.71M | 6.71M | 4.69M | 34.16M | 2.38M | 2.12M | 2.19M | 2.1M | 2.03M | 2.84M | 3.43M | 2.76M | 2.23M | 2.62M | 2.11M | 2.01M | 2.22M | 1.4M |
| Other Countries Revenue Growth | -5.74% | -10.63% | +24.93% | +13.21% | -31.33% | +56.38% | -9.44% | -45.91% | +35.82% | +16.00% | +10.62% | -14.73% | -29.89% | +43.03% | -86.27% | +1332.41% | +12.61% | -3.46% | +4.33% | +3.65% | -28.58% | -17.08% | +24.00% | +23.79% | -14.94% | +24.18% | +5.02% | -9.37% | +58.57% | n/a |
| Rest Of Asia Pacific Revenue | 24.67M | 23.38M | 27.32M | 27.15M | 25.33M | 27.26M | 25.79M | 24.06M | 27.39M | 28.11M | 27.2M | 26.89M | 23.09M | 22.84M | 24.43M | n/a | 22.76M | 20.75M | 18.38M | 16.41M | 17.84M | 21.7M | 24.22M | 24.22M | 20.7M | 20.45M | 29.71M | 24.88M | 24.99M | 24.72M |
| Rest Of Asia Pacific Revenue Growth | +5.51% | -14.42% | +0.63% | +7.16% | -7.05% | +5.69% | +7.19% | -12.16% | -2.56% | +3.36% | +1.15% | +16.44% | +1.09% | -6.52% | n/a | n/a | +9.71% | +12.89% | +11.97% | -8.00% | -17.78% | -10.41% | +0.01% | +16.98% | +1.25% | -31.18% | +19.41% | -0.42% | +1.08% | n/a |
| Rest Of Europe Revenue | 34.85M | 31.78M | 34.79M | 30.58M | 32.53M | 30.97M | 38.87M | 34.26M | 34.54M | 29.36M | 32.48M | 34M | 37.92M | 33.37M | 33.52M | n/a | 35.6M | 35.58M | 32.76M | 30.48M | 30.71M | 33.09M | 32.41M | 30.49M | 35.97M | 30.77M | 24.98M | 30.22M | 23.35M | 27.06M |
| Rest Of Europe Revenue Growth | +9.65% | -8.64% | +13.75% | -5.98% | +5.03% | -20.32% | +13.46% | -0.81% | +17.61% | -9.58% | -4.47% | -10.34% | +13.62% | -0.45% | n/a | n/a | +0.07% | +8.60% | +7.47% | -0.75% | -7.17% | +2.07% | +6.31% | -15.24% | +16.90% | +23.18% | -17.35% | +29.45% | -13.72% | n/a |
| United States Revenue | 128.12M | 123.65M | 122.31M | 124.33M | 123.39M | 117.08M | 96.37M | 110.46M | 107.59M | 103.84M | 103.76M | 99.23M | 86.65M | 82.72M | 79.13M | n/a | 59.5M | 59.23M | 54.4M | 57.63M | 54.52M | 59.2M | 64.23M | 63.28M | 62.01M | 64.76M | 60.59M | 63.07M | 60.47M | 58.11M |
| United States Revenue Growth | +3.62% | +1.09% | -1.62% | +0.76% | +5.39% | +21.49% | -12.76% | +2.67% | +3.61% | +0.08% | +4.57% | +14.52% | +4.76% | +4.53% | n/a | n/a | +0.45% | +8.89% | -5.62% | +5.71% | -7.91% | -7.82% | +1.51% | +2.04% | -4.25% | +6.88% | -3.94% | +4.31% | +4.05% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 27, 2025 | Mar 28, 2025 | Dec 31, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 31, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Dec 31, 2020 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 47.1M | 45.6M | 43.3M | 44.32M | 44.79M | 43.53M | 41.7M | 39.65M | 42.19M | 40.92M | 38.71M | 40.3M | 40.54M | 39.35M | 34.97M | 31.3M | 31.24M | 31.65M | 27.4M | 26.79M | 24.91M | 30.75M | 29.43M | 27.93M | 29.2M | 31.85M | 28.3M | 29.15M | 29.23M | 29.22M | 27.36M | 27.72M | 23.94M | 23M | 19.33M | 20.97M | 20.2M | 21.19M | 19.08M | 19.98M | 20.92M | 22.07M |
| Selling, General, and Administrative Revenue Growth | +3.31% | +5.30% | -2.30% | -1.06% | +2.90% | +4.38% | +5.18% | -6.02% | +3.09% | +5.72% | -3.95% | -0.58% | +3.01% | +12.54% | +11.73% | +0.18% | -1.30% | +15.51% | +2.29% | +7.55% | -19.01% | +4.50% | +5.39% | -4.38% | -8.30% | +12.53% | -2.90% | -0.29% | +0.04% | +6.80% | -1.32% | +15.80% | +4.09% | +18.97% | -7.81% | +3.83% | -4.67% | +11.04% | -4.50% | -4.51% | -5.19% | n/a |
| Research and Development Revenue | 25.29M | 23.24M | 25.29M | 23.25M | 23.73M | 23.25M | 23.45M | 22.02M | 23.38M | 22.83M | 21.9M | 21.35M | 21.59M | 20.93M | 19.42M | 17.47M | 16.95M | 18.68M | 15.99M | 15.23M | 14.44M | 15.33M | 14.77M | 13.81M | 13.39M | 14M | 13.28M | 13.2M | 12.55M | 11.99M | 11.79M | 11.66M | 9M | 9.21M | 7.97M | 7.96M | 8.02M | 8.05M | 7.29M | 7.69M | 7.84M | 8.21M |
| Research and Development Revenue Growth | +8.83% | -8.10% | +8.74% | -2.01% | +2.09% | -0.88% | +6.49% | -5.81% | +2.42% | +4.22% | +2.60% | -1.11% | +3.15% | +7.78% | +11.16% | +3.03% | -9.25% | +16.83% | +4.99% | +5.48% | -5.83% | +3.83% | +6.94% | +3.16% | -4.35% | +5.40% | +0.58% | +5.20% | +4.69% | +1.64% | +1.17% | +29.49% | -2.29% | +15.58% | +0.15% | -0.69% | -0.45% | +10.38% | -5.17% | -1.88% | -4.56% | n/a |